Concepedia

H. S. Rasmussen

HS

Statistics

Publications

4

Citations

201

H-Index

4

Active since

1991

Affiliations

Pfizer (United Kingdom)(Current)

H. S. Rasmussen is an author at Pfizer (United Kingdom) specializing in pharmacology, antiarrhythmic therapy, and antiarrhythmic drug effects.

Publications per year

1991–1992

4

Publications

4

Pharmacokinetics and metabolism of dofetilide in mouse, rat, dog and man

Dennis A. Smith, H. S. Rasmussen, D. A. Stopher et al. · Xenobiotica · 1992 · 64 citations

, , +15

Dofetilide, A Novel Class III Antiarrhythmic Agent

H. S. Rasmussen, Michael J. Allen, Kenneth J. Blackburn et al. · Journal of Cardiovascular Pharmacology · 1992 · 59 citations

, , +17

Pharmacokinetic and pharmacodynamic effects of UK‐68,798, a new potential class III antiarrhythmic drug.

Martin L. Sedgwick, H. S. Rasmussen, Don K. Walker et al. · British Journal of Clinical Pharmacology · 1991 · 47 citations · Full text

, , +17

A dose‐ranging study of UK‐68,798, a novel class III anti‐arrhythmic agent, in normal volunteers.

JD Gemmill, CA Howie, PA Meredith et al. · British Journal of Clinical Pharmacology · 1991 · 31 citations · Full text

, , +17

1–4 of 4